Form 4 for IRON Disc Medicine, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-003075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-05 | 2026-01-02 | IRON | Khara Rahul | CLO | S - Sale+OE | $78.68 | -6,500 | 43.9K | -13% | -$511.4K |
| DT | 2026-01-05 | 2026-01-02 | IRON | Khara Rahul | CLO | M - OptEx | $13.50 | +6,500 | 44.3K | +17% | +$87.8K |
| DT | 2026-01-05 | 2026-01-02 | IRON | Khara Rahul | CLO | M - OptEx | $0.00 | -6,500 | 22.3K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | S | D | 1,157 | $79.27 | 37,793 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.49, inclusive. (F2) Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. |
| 2 | Common | Common Stock | 2026-01-02 | S | D | 4,993 | $78.62 | 38,950 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive. (F2) Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. |
| 3 | Common | Common Stock | 2026-01-02 | M | A | 6,500 | $13.50 | 44,293 | D | — | — | (F2) Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. |
| 4 | Common | Common Stock | 2026-01-02 | S | D | 350 | $77.67 | 43,943 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.09 to $78.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (5) to this Form 4. (F2) Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | M | D | 6,500 | $0.00 | 22,270 | D | $13.50 · — to 2032-12-28 | 6,500 Common Stock | (F6) The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. |